Takeda Pharmaceutical
TAK
#473
Rank
S$67.24 B
Marketcap
S$21.28
Share price
-0.06%
Change (1 day)
19.72%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): S$4.19 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are S$29.86 Billion. , an increase over its 2024 earnings that were of S$2.85 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 S$4.25 B49.03%
2024 S$2.85 B-2.41%
2023 S$2.92 B-28.14%
2022 S$4.07 B-40.9%
2021 S$6.89 B78.24%
2020 S$3.86 B246.1%
2019 S$1.11 B-48.79%
2018 S$2.18 B-23.64%
2017 S$2.85 B21.7%
2016 S$2.34 B-253.01%
2015 -S$1.54 Billion-159.65%
2014 S$2.57 B13%
2013 S$2.27 B2.46%
2012 S$2.22 B-57.05%
2011 S$5.17 B-10.49%
2010 S$5.77 B-3.99%
2009 S$6.01 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.24 B 681.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.19 B 374.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$13.55 B 218.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.62 B 173.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.80 B 130.28%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$16.83 B 295.47%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$12.81 B 201.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-S$1.02 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
S$1.11 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India